Purchase Order 36C24823P0935
Award Date
3/7/23
Potential Completion Date
3/24/23
Potential Value
$44K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Cardinal Health 414, LLC
Ultimate Awardee
Cardinal Health, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Dublin, OH 43017, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $12,623.78 firm fixed-price purchase order awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the U.S. Department of Veterans Affairs (VA), to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the supply of the radiopharmaceutical product XOFIGO, used in the treatment of prostate cancer. Cardinal Health 414 is a key provider of radiopharmaceuticals, radioactive isotopes, and specialty pharmaceuticals to federal healthcare...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $645,701.90 firm-fixed-price delivery order contract to Cardinal Health 414, LLC for the radiopharmaceutical product XOFIGO. This order is part of the company's existing multi-year indefinite delivery contracts valued up to $39.8 million to provide radiopharmaceuticals and related supplies to VA medical centers and networks nationwide. Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., is a major...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare company Cardinal Health, Inc. The $214,933.60 firm fixed-price purchase order contract is for the delivery of the radiopharmaceutical drug XOFIGO, which is used in the treatment of cancer. The contract has a completion date of January 5, 2021. Cardinal Health 414 has provided a range of pharmaceutical products and services,...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical product XOFIGO, with a potential value of $439,632. It is a firm fixed price delivery order contract that does not have a set-aside designation. Cardinal Health 414 has provided a range of pharmaceutical products and services, including radiopharmaceuticals, to...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order contract to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the delivery of the radiopharmaceutical product XOFIGO, with a potential value of $150,000.00. The contract has a completion date of June 1, 2024. Cardinal Health 414 has previously held multiple indefinite delivery contracts to provide radiopharmaceuticals, specialized pharmaceuticals, and...
This is a $215,099 firm-fixed-price purchase order awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 4 (VISN 4). The contract is for the delivery of the radiopharmaceutical drug XOFIGO (radium-223 dichloride) through June 2025. Cardinal Health 414 is a major supplier of radiopharmaceuticals and specialized pharmaceutical products to federal healthcare agencies like the VA, Department of...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc. The contract is for the radiopharmaceutical product XOFIGO, with a firm fixed price of $354,532.78 and a completion date of January 5, 2021. Cardinal Health 414 has provided a range of pharmaceutical products and related services, including radiopharmaceuticals, to the VA, Department of Defense, National Institutes of...
This federal contract award is for the delivery of RADIUM 223 XOFIGO, a radiopharmaceutical product, to the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 17. The contract was awarded to Cardinal Health 414, LLC, a subsidiary of Cardinal Health, Inc., a global healthcare services company. The contract has a potential value of $382,864.08 and is a firm fixed price delivery order with no set-aside designation. Cardinal Health 414 has provided...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract provides for the delivery of the nuclear medicine product Xofigo on a firm fixed price basis, with a potential value of $417,586.68. Cardinal Health 414 has held multiple indefinite delivery contracts (IDVs) with the VA to supply radiopharmaceuticals, radioactive...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Cardinal Health 414, LLC, a subsidiary of the global healthcare services company Cardinal Health, Inc. The contract is for the provision of XOFIGO INJECTION MEDICINE, a radiopharmaceutical cancer treatment, to VA health facilities. The contract is a firm fixed price purchase order with a potential value of $303,941.11 and a completion date of December 31, 2019. No set-aside...